Spero Therapeutics, Inc.
For the period ended Oct 26, 2026. Filed Oct 27, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Oct 26, 2026 · Filed Oct 27, 2026
SPRO$1.03+1.0%Stored close · as of Nov 6, 2026
Opening this filing…